Finally Cleared for Surgery

Article

After being declared cancer-free, Ed found himself back in the doctor's office again.

One month has passed since the oncologist declared Ed cancer-free. Now he was back in Dr. Asif’s office for a one-month follow up.

“Well”, spoke Dr. Asif, “Have you had your aortic valve implant?”

“No,” Ed replied

“Oh,” Dr. Asif responded. “Why not? I cleared you with the cardiologist.”

Ed began to explain how he spent a week in Washington Med Star undergoing evaluation for the procedure only to be rejected because approval from the FDA was not forthcoming for the experimental implant of an artificial aortic valve by catheterization. Ed’s situation was just not critical enough for the minimally invasive procedure. However, the staff at Washington Med Star agreed that Ed needed aortic valve replacement by open heart surgery and it needed to be done very soon.

“Have you been scheduled for that surgery?” inquired Dr. Asif.

“Yes”, Ed replied,” It will be done next week at Peninsula Regional Medical Center in Salisbury, Maryland.”

“All right,” Dr. Asif responded, “I will send my concurrence to Dr. Sunnergren, your cardiologist. Your white cell count has dropped since lasted month, but you are still OK to proceed with the surgery. I do want to see you again one month after surgery. You are mildly anemic and we may need to start you on an iron infusion. I will schedule you for a blood draw and visit with me. The staff will notify you.”

Ed has been through quite a lot in the past three years, and the closer it got to the date of his open-heart surgery, the more his anxiety started to mount. Ed had requested a prescription for tranquilizers, which was provided by the heart surgeon. Ed had the prescription filled but never took a single pill. That strange emotion, he has felt before, was overwhelming him. Hope was still there and comforting.

The surgery went very well and when Ed awoke from the anesthesia, all the anxieties were gone.

Ed’s recovery was rapid and Ed left the hospital after a few days and entered home care nursing. After one week, the visiting nurse released Ed from care because he had recovered so quickly. Ed thought, “It was because of Pattie my wife and caregiver.”

The past three years had been hard on her too, but she never gave up hope and supported and cared for Ed all the time. Three weeks later, Ed was back in Tunnel Cancer Center for lab work preceding his monthly follow up with Dr. Asif.

Dr. Asif reviewed the lab results and informed Ed he had become very anemic. His white cell count had dropped by 50 percent since his last visit only one month ago and was down to 2000.

“We must start the iron infusion right away. I am ordering an injection of Filgrastim today before you leave. Ferric Carboxymaltose will be given next week by infusion to help counter the anemia. We will begin monthly injections of Vitamin B12. These will all help to strengthen your immune system.”

The following week, Ed arrived for his iron infusion. As he was in the waiting area, Kimberly, one of the nurses from the infusion room, came to escort him back into the infusion room. Once more, Ed’s weight was recorded and he answered the 20 questions, while Nurse Lisa helped hook-up the plumbing for the infusion.

The infusion began slowly as always but would be increased when the nurses could determine Ed was not going to have an adverse reaction to the ferric carboxymaltose.

It was almost like “old home week” as Ed renewed acquaintances with the nursing staff in the infusion room. Soon, after about two hours, the infusion was complete and Ed was released.

There are some possible side effects to taking ferric carboxymaltose but the only thing Ed noticed was spells of vertigo, which were bothersome, but began to subside after two weeks. Ed did not like that feeling of dizziness and would recline is his chair until it passed.

Only two more ferric carboxymaltose injections to go, one month apart.

The peace of feeling, the comfort of being well, recovered and in remission was something Ed had not felt for quite some time.

“Be anxious for nothing, but in everything by prayer and supplication, with thanksgiving, let your requests be made known to God; and the peace of God, which surpasses all understanding, will guard your hearts and minds through Christ Jesus.”---Philippians 4: 6-7

Related Videos
Image of Meaghan Mooney at the 2024  Extraordinary Healer Award event.
Video 4 - "Current First-Line Treatment Options in CLL"
Video 3 - "Goals of Treatment for Patients With CLL"
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL